NovoCure (NVCR) Work In Process (2014 - 2019)

NovoCure (NVCR) has reported Work In Process for 6 consecutive years, with $9.1 million the latest figure, recorded in Q2 2019.

• Quarterly Work In Process rose 73.08% year-over-year to $9.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $9.1 million (up 73.08% YoY) and the FY2018 annual result came in at $8.7 million, up 2.75% from the prior year.
• Work In Process climbed to $9.1 million in Q2 2019 per NVCR's latest filing, from $8.2 million in the prior quarter.
• Over the last five years, Work In Process for NVCR reached as high as $11.0 million in Q2 2017 and fell as low as $3.2 million in Q3 2015.
• A 5-year average of $7.5 million and a median of $8.2 million in 2016 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2015 — Work In Process soared 260.78% — and 2018, when it sank 51.99%.
• Year by year, Work In Process stood at $4.6 million in 2015, then soared by 79.56% to $8.3 million in 2016, then climbed by 1.72% to $8.4 million in 2017, then advanced by 2.75% to $8.7 million in 2018, then gained by 5.18% to $9.1 million in 2019.
• According to Business Quant data, Work In Process over the past three periods registered $9.1 million, $8.2 million, and $8.7 million for Q2 2019, Q1 2019, and Q4 2018 respectively.